Newsletter
Sign up for the Fund's newsletter and get the lastest news, calls and events
| Titel Sort descending | Periode | Program | |
|---|---|---|---|
| UV-light disinfection of venous catheters | 2019 - 2020 | Innobooster
|
|
|
UV-light disinfection of venous catheters
Period
2019 - 2020
Region
Region Sjælland Program
Innobooster Area
Biotek, Medico og Sundhed Investment
Percentage
30.46 Invested
499.000 Budget
1.6 mill. Partners
UV Clinical People
UV Clinical ApS
Read more about the project
| |||
| uvc-box uvc-box | 2020 - 2020 | Grand Solutions
|
|
|
uvc-box uvc-box
Period
2020 - 2020
Region
Region Sjælland Program
Grand Solutions Area
Ikke defineret Investment
Percentage
35 Invested
393.750 Budget
1.1 mill. Partners
Voss Industry A/S People
VOSS INDUSTRY A/S
Read more about the project
| |||
| Uvisa Health: Medical Device to Treat Vaginitis | 2022 - 2023 | Innofounder
|
|
|
Uvisa Health: Medical Device to Treat Vaginitis
Period
2022 - 2023
Region
Region Hovedstaden Program
Innofounder Area
Ikke defineret Investment
Percentage
100 Invested
760.000 Budget
760.000 Partners
Uvisa Health ApS People
Uvisa Health ApS
Read more about the project
| |||
| UVision-Sensor til lokationsbestemmelse under vand | 2022 - 2023 | Innofounder
|
|
|
UVision-Sensor til lokationsbestemmelse under vand
Period
2022 - 2023
Region
Region Hovedstaden Program
Innofounder Area
Ikke defineret Investment
Percentage
100 Invested
430.000 Budget
430.000 Partners
UVision ApS People
UVision ApS
Read more about the project
| |||
| UVSOLAR Ultra-Violet supercontinuum sources and pulsed lasers for the solar cell and semiconductor industry | 2023 - 2026 | Grand Solutions
|
|
|
UVSOLAR Ultra-Violet supercontinuum sources and pulsed lasers for the solar cell and semiconductor industry
Period
2023 - 2026
Region
Program
Grand Solutions Area
Ikke defineret Investment
Percentage
71.97 Invested
20.4 mill. Budget
28.3 mill. High brightness supercontinuum and tunable UV lasers have a wide range of applications in scientific and industrial markets including solar cell and semiconductor manufacturing, microscopy and lithography. Current supercontinuum lasers are limited to the visible and infrared spectral regions. Adding Vacuum UV below 200 nm (VUV) to the spectral range of these sources opens new important application areas in manufacturing and optical analysis. In a previous project by NKT, DTU, and DFM (UVSUPER), a novel approach was taken using an NKT-patented hollow-core optical fiber. Pressurizing this fiber with the noble gas argon and pumping it with short high-energy pulses allowed the generation of a broadband supercontinuum inside the hollow-core with a spectrum that reached down to 200 nm.
In UVSOLAR we aim at: (1) improving the TRL level of the existing solution to TRL7 and extend the spectrum to Vacuum UV (VUV) 150 nm by using other noble gasses and by maturing the pump compression of the UV-module, the high pulse-energy fiber coupling, and the gas cell stability and pressure control: (2) demonstrating the added value of the laser system compared to existing supercontinuum and UV lasers in a number of key high-end commercial applications. These demonstrations include thin film solar cell scribing (Sunplugged), silicon solar cell laser doping (Topsil), DUV and VUV microscopy and scatterometry (DeltaPix and DFM) and semiconductor processing (3D Micromatic and KLA-Tencor - LoI)
Partners
NKT Photonics, Technical University of Denmark, DANSK FUNDAMENTAL METROLOGI A/S, Aarhus University, Topsil GlobalWafers A/S, Sunplugged, DeltaPix People
Read more about the project
| |||
| Vaccine Expanded Human T cells Targeting Endogenous Retrovirus-K in Human Cancer Cells | 2019 - 2022 | Industrial Researcher
|
|
|
Vaccine Expanded Human T cells Targeting Endogenous Retrovirus-K in Human Cancer Cells
Period
2019 - 2022
Region
Region Hovedstaden Program
Erhvervsforsker Area
Biotek, Medico og Sundhed Investment
Percentage
42.03 Invested
1.1 mill. Budget
2.6 mill. Partners
University of Copenhagen, INPROTHER ApS People
INPROTHER ApS
Read more about the project
| |||
| Vaerks - Digital Produktion | 2021 - 2022 | Innobooster
|
|
|
Vaerks - Digital Produktion
Period
2021 - 2022
Region
Region Hovedstaden Program
Innobooster Area
Ikke defineret Investment
Percentage
32.95 Invested
383.000 Budget
1.2 mill. Partners
Vaerks ApS People
EasyPartz ApS
Read more about the project
| |||
| Vaerks - Plug&Play CNC Bearbejdning | 2021 - 2022 | Innofounder
|
|
|
Vaerks - Plug&Play CNC Bearbejdning
Period
2021 - 2022
Region
Region Hovedstaden Program
Innofounder Area
Produktion, Materialer, Digitalisering og IKT Investment
Percentage
100 Invested
920.000 Budget
920.000 Partners
EasyPartz ApS People
EasyPartz ApS
Read more about the project
| |||
| Vaerks - Simpel CNC bearbejdning | 2019 - 2020 | Innobooster
|
|
|
Vaerks - Simpel CNC bearbejdning
Period
2019 - 2020
Region
Region Hovedstaden Program
Innobooster Area
Produktion, Materialer, Digitalisering og IKT Investment
Percentage
32.91 Invested
439.350 Budget
1.3 mill. Partners
Vaerks IVS People
EasyPartz ApS
Read more about the project
| |||
| Vaginal proteomics to characterize the immune-microbiome interface | 2026 - 2029 | Industrial Researcher
|
|
|
Vaginal proteomics to characterize the immune-microbiome interface
Period
2026 - 2029
Region
Program
Erhvervsforsker Area
Ikke defineret Investment
Percentage
32.83 Invested
1.1 mill. Budget
3.3 mill. Bakteriel ubalance I underlivet påvirker op mod 25% af kvinder og kan medføre mange komplikationer, såsom nedsat fertilitet, tidlig fødsel, samt øget risiko for kønssygdomme. Gennem metaproteom-analyser vil dette projekt forsøge at kortlægge forskelle I proteinsammensætningen i det vaginale mikrobiom, som kan adskille ubalance fra balance samt afspejle behandlingsrespons i kvinder. Resultaterne skal bruges til at identificere kliniske biomarkører og dermed støtte præcisionsbehandling.
Partners
Freya Biosciences ApS, University of Copenhagen People
University of Copenhagen
Read more about the project
| |||
| Vahle - New Future | 2015 - 2016 | Innobooster
|
|
|
Vahle - New Future
Period
2015 - 2016
Region
Region Midtjylland Program
Innobooster Area
Ikke defineret Investment
Percentage
100 Invested
100.000 Budget
100.000 Partners
VAHLE A/S People
VAHLE A/S
Read more about the project
| |||
| Vakuum Icemaker | 2016 - 2016 | Innobooster
|
|
|
Vakuum Icemaker
Period
2016 - 2016
Region
Region Midtjylland Program
Innobooster Area
Ikke defineret Investment
Percentage
32.88 Invested
480.000 Budget
1.5 mill. Partners
RINGKØBING MASKINVÆRKSTED A/S People
RINGKØBING MASKINVÆRKSTED A/S
Read more about the project
| |||
| Validating novel biomarkers for Huntington's | 2024 - 2025 | Innobooster
|
|
|
Validating novel biomarkers for Huntington's
Period
2024 - 2025
Region
Program
Innobooster Area
Ikke defineret Investment
Percentage
35 Invested
2.3 mill. Budget
6.5 mill. Partners
Teitur Trophics People
Read more about the project
| |||
| Validation of lower-leg accelerometer-based tracking technology in football | 2023 - 2026 | Industrial Researcher
|
|
|
Validation of lower-leg accelerometer-based tracking technology in football
Period
2023 - 2026
Region
Program
Erhvervsforsker Area
Ikke defineret Investment
Percentage
52.7 Invested
1.1 mill. Budget
2.0 mill. Dette projekt har til formål at undersøge anvendeligheden af accelerometer-baseret monitorerings-teknologi ved kvantificering af de fysiske krav i fodbold, og i relation til de tekniske og taktiske aspekter af spillet hos både mænd og kvinder. Studiet vil blive udført ved hjælp af video og GPS-data for at validere denne nye teknologi. Forskningen har ydermere til formål at belyse effekten af den kvindelige cyklus på disse tre områder, hvilket der generelt mangler forskning omkring.
Partners
University of Copenhagen, Next11 Technologies ApS People
Read more about the project
| |||
| Validation of novel detoxification platform turning bacterial toxins into vaccine antigens | 2019 - 2020 | Innobooster
|
|
|
Validation of novel detoxification platform turning bacterial toxins into vaccine antigens
Period
2019 - 2020
Region
Region Hovedstaden Program
Innobooster Area
Biotek, Medico og Sundhed Investment
Percentage
27.8 Invested
496.000 Budget
1.8 mill. Partners
Proxi Biotech People
PrOxi Biotech ApS
Read more about the project
| |||